TWI230734B - Control of the T7 expression system by L-arabinose - Google Patents

Control of the T7 expression system by L-arabinose Download PDF

Info

Publication number
TWI230734B
TWI230734B TW91113315A TW91113315A TWI230734B TW I230734 B TWI230734 B TW I230734B TW 91113315 A TW91113315 A TW 91113315A TW 91113315 A TW91113315 A TW 91113315A TW I230734 B TWI230734 B TW I230734B
Authority
TW
Taiwan
Prior art keywords
arabinose
protein
strain
gene
recombinant
Prior art date
Application number
TW91113315A
Other languages
Chinese (zh)
Inventor
Yun-Peng Chao
Chung-Jen Chiang
Wen-Bin Hung
Wei-Shing Lin
Original Assignee
Widetex Biotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Widetex Biotech Co Ltd filed Critical Widetex Biotech Co Ltd
Priority to TW91113315A priority Critical patent/TWI230734B/en
Application granted granted Critical
Publication of TWI230734B publication Critical patent/TWI230734B/en

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention is drawn to processes for biologically controlling T7 expression system in Recombinant Escherichia coli strain BL21 (BAD) by using L-arabinose to active T7 promoter. The strain BL21 (BAD) are useful to produce a variety of heterologous proteins. Also disclosed is abiologically large scale operations of the strain BL21(BAD), it is convenient to carry out the culture in a fermentation tank with two-stages carbon source and stage input system.

Description

1230734 九、發明說明: 【發明所屬之技術領域】 本發明係關於一種以誘導物控制大腸桿菌中基因表 ,載體(expression vector)的方法,更明確的是,二發明 是一種以左旋阿拉伯糖誘導方式來控制T7表達系統的 控制方法’此方法佐以二階段碳源和區段式進料的饋料 批次發酵策略,以達到大量生產重組蛋白質的目的。 【先前技術】 發明背景 以生物細胞來生產具有商業價值或醫療用途的重組 蛋白質(recombinant proteins)可謂是一項極為重要且 具經濟剞瞻性的生技產業。大體而言,可用來作為蛋白 貝生產的生物細胞包括微生物、昆蟲、動物和植物細胞 4,其中又以利用微生物細胞來生產重組蛋白質的方法 較具經濟競爭力,其原因在於微生物細胞較易大量培 養、生長快速和培養所需營養基質配方簡單且價格低 廉。過去數十年來,由於許多的科學研究均以大腸桿菌 (Escherichia coli)作為核心主題,學術界因此累積了 龐大且詳盡的攸關此菌種之生化相關知識,無疑的,發 展大腸桿菌以製造重組蛋白質的生產系統相對的也較使 用其他生物細胞發展的系統更為成功。 1230734 為期利用生物細胞達到有效生產蛋白質的目的,基 因表達載體(expression vectors)是一項不可或缺的利 器,在大腸桿菌中有許多針對不同需求而發展出來的基 因表達載體(Markides, Microbiol· Rev·,60:512-538, 1996),其中最為實驗室普遍使用的首推T7表達系統(T7 expression system) 〇 Τ7表達系統包含Τ7 RNA聚合酉 每 (T7 RNA polymerase)和一個能被T7 RNA聚合酉 每 驅動的T7啟動子(T7 promoter)。T7 RNA聚合酉 每是噬菌體(phage) T7基因1 ( T7 gene 1 )的產物, 相較於大腸桿菌的RNA聚合酉每,它對於選殖基因 (cloned gene )具有極為優越的轉錄(transcription ) 能力(Colomb and Chamberlin, J. Biol· Chem·, 249:2858-2863, 1974),再貝丨J它對於T7啟動子特具專一 性(Tabor and Richardson, Proc. Natl. Acad· Sci· USA, 82:1074-1078,1985 ),基於 T7 RNA 聚合酉每 的專一選擇性和優越轉錄能力,Studier等人(Studier and Moffatt, J. Mol. Biol. 189:113-130, 1986; Studier et al·,U. S. patent 4,952,496,1990)首先據此發展 T7 表 達系統。此系統包含一株重組菌種BL21 (DE3)和一個含 有T7啟動子的基因表達質體,而重組菌種BL21(DE3) 的染色體上則含有一個以丨acUV5啟動子控制的T7基因 1230734 在T7表達系統中,雖然片 ^蛋白質的方法極為:从誘導生產目 物質價格昂貴 合易知作’然而加入的化學 功用的蛋白入:且Γ酵母液’不利於生產具醫療 蛋白貝❿且無法達到均勻誘導每—細胞。 —種習知技術係以化併 七.0galact〇pyran〇si 匆貝 /3 生產大量的重組蛋白質丄)為严―物’使菌種可以 產蛋白質的基因表達質體#且 ”、、 模使用、,、有成項要件··即在發酵規 具有”且經濟的誘導方式、高基因表達能力 然無法達到4化❹,日t 式表達系統顯 業化使用之目的,其原因為⑴IPTG的 貝’(2) |PTG不被細菌細胞代謝,而容易造成發 酵液的染而使得發酵產品純化不易’(3) IPTG且有潛 在的毒性’因此不適用在生產醫療用的產品, ⑽’ 52:713-722, 1988),(4)由於丨acUV5啟動子的調 控性不夠嚴謹而導致菌種BL21(DE3)在非誘導情況下即 產生微量的T7RNA聚合酉每’造成選殖在質體上以T7 啟動子控制表達的目標基因產物因而產生,尤其是目標 基因產物對於宿主細胞具有潛在毒性時,細胞的生長將 會叉到抑制,進而使得含目標基因的質體產生不穩定的 現象(Studier et al_,Methods in Enzymology,185:60-89, 1991 )’這些缺點顯然限制了 T7表達系統的工業實用性。 1230734 在另一習知技術 Wycuff 和 Mattews (Anal. Biochem·,277:67-73,2000),曾發展以 araBAD 啟動子 調控T7基因1,進而控制選殖在T7啟動子下的目標基 因之表達。然而,該習知技術係將受araBAD啟動子調 控的T7基因1選殖在具pACYCI 84複製源點(origin)的 質體上,所以導致過高未誘導時蛋白質的生成,並不適 合用來生產具有潛在毒性的重組蛋白質。 1230734 【發明内容】 發明概述 過去的研究發現,能被左旋阿拉伯糖誘導的araSAD 啟動子具有嚴密調控性(tight regulation)、迅速被誘導 活化(prompt activation )和高基因表達能力(high-level expression )等特性(Guzman et al·,J. Bacteriol·, 177:4121-4130, 1995),因此本發明特別以左旋阿拉伯糖 為誘導物應用在控制T7表達系統。 本發明的主要目的旨在提供一種以誘導物控制大腸 桿菌中的T7表達系統的方法,以便改善T7表達系統並 使其具有工業實用性。 本發明的另一目的,係利用左旋阿拉伯糖為誘導 物,以控制T7表達系統的方法,並配合二階段碳源和區 段式進料發酵策略,而達到使菌種大量生產重組蛋白質。 本發明係建構一株能以左旋阿拉伯糖來誘導生產T7 RNA聚合酉每的重組菌種BL21(BAD),此菌種的染色體 上箝含有以ara^AD啟動子控制的T7基因1和araC控 制基因(regulatory gene)。基本上,AraC控制蛋白質 (regulatory protein)與左旋阿拉伯糖結合所形成的複 合蛋白質可以驅動活化araS/\D啟動子,而AraC控制蛋 1230734 白質本身則具有抑制araS/AD啟動子之效能,因此重組 菌種T7 RNA聚合酉每的生產實繫於左旋阿拉伯糖的存 在與否,而選殖在T7啟動子下游的目標基因之表達自然 為左旋阿拉伯糖所控制。 在本發明的一種較佳實施例中,以生產 Agrobacterium radiobacter NRRL B11291 的 carbamoylase蛋白質為例,未加入左旋阿拉伯糖誘導 時,carbamoylase在菌種BL21(BAD)中幾乎沒有生成, 然而以300//Μ左旋阿拉伯糖誘導時,菌種BL21 (BAD) 即生產高達30%總細胞蛋白質量的carbamoylase,這個 結果顯示本發明發展的系統具有工業發酵生產重組蛋白 質的潛能。以高細胞密度饋料批次發酵並施以足量的左 旋阿拉伯糖誘導,菌種BL21(BAD)可以生產多出以搖瓶 發酵生產所得蛋白質1000倍以上的量。 在整個饋料批次發酵步驟中係應用「二階段碳源方 法」,在初期發酵階段使用葡萄糖以穩定重組質體,而在 進料階段,則以葡萄糖和甘油混合物以利誘導效能和降 低成本。此外,為達大量生產重組蛋白質的目的,本發 明在進料階段更進一步發展「區段式進料法」以達高細 胞密度發酵。在加入適量的左旋阿拉伯糖或是大豆萃取 液誘導,菌種BL21 (BAD)可以生產多出以搖瓶規模生產 1230734 所得蛋白質1000倍以上的量。綜合言之,本發明發展的 系統具有以下多項優點: (1) 可以左旋阿拉伯糖誘導來生產重組蛋白質,左旋阿拉 伯糖的來源可取自植物如大豆萃取液,不但價格較有經 濟競爭性而且可為細菌代謝分解而不造成發酵液污染。 (2) araBAD啟動子極具敏感性,1 〇 # μ的左旋阿拉伯糖 即可誘導重組菌種生產大量的蛋白質。 (3) 本發明菌種BL21(BAD)極具穩定性可以維持含 ca「bam〇y|ase基因質體100%穩定度達1〇〇細胞世代 (generations),相對的菌種BL21(DE3)只可維持相同 的質體穩定度僅達20細胞世代。 (4) 本發明發展的r區段進料式」發酵策略可將本發明菌 種以發酵槽規模培養至高細胞密度,細胞密度達每升 37·5 9乾重細胞。 (5) 本發明發展的「二階段碳源方法」策略可有效維持重 組質體的穩定性,以1-2%的大豆萃取液誘導本發明發展 的菌種,菌種可產生高出搖瓶規模1〇〇〇倍的重組蛋^ 貝’由此顯示結合本發明發展的發酵方法和本發明所建 構的菌種BL21(BAD)可以用來大量生產重組蛋白質,實 具有工業實用性。 、 1230734 【實施方式】 發明之詳細說明 本發明以左旋阿拉伯糖誘導方式來控制T7表達系 統的控制方法,包含以下步驟: 建構株重組菌種,該重組菌種含有—個内含了7啟動子 的質體’且該重組菌種的染色體上箝含有卩啟 動子控制的T7基因1和arac控制基因; 以饋料批次發酵方法培養該重組菌種,在批次發酵階 段,提供的發酵液中含有葡萄糖為碳源,而在進料階段, 提供的進料液巾含有甘油和㈣糖為碳源,使達到高細 胞密度發酵;以及 在細胞達到-定高密度後,加人含有左旋阿拉伯糖 的誘導物’使該重組菌種產生一重組蛋白質。 本發明的控制方法’進一步地包含:以左旋阿拉伯 糖誘導建構出的重組菌種BL21(BAD),進行異源蛋白質 (hetero丨ogous pr〇tejn)搖瓶規模的生產而在此處選 擇生產異源蛋白質係作為檢測模式。 以下伴匕著相關圖示並經由圖例說明本發明的原 理’而詳細揭露本發明的其他方面和優點。 ” (一)、建構重組菌種BL21 (BAD) 12 1230734 為了發展以左旋阿拉伯糖來控制T7表達系統,首先將建 構一株重組菌種使其染色體上箝含有一個以araBAD啟 動子調控的T7基因1和araC控制基因。 A. T7基因1的選殖操作 (1) 基因選殖使用的菌種和搖瓶培養方式 基因選殖過程中均採用大腸桿菌DH5a(deoR endA1 g yr96 hsdR17 supE444 thi △(lacIZYA-argF 169) rec A1 lacZM15),液態培養菌種時,首先由固態培養孤中 點取數顆菌落至含營養基值的搖瓶中,在37°C、每分鐘 200轉條件的水浴旋轉培養槽中培養過夜,隔日以百倍 稀釋的體積取出菌液並接種至含新鮮營養基質的搖瓶 中,依相同培養條件繼續培養。營養基質的成分是需求 而定,在本例中採用Luria-Bertani (LB)營養基在下培 養。而抗生素也視需要而決定是否加入培養基中,在本 例中則加入抗生素安培西林(ampicillin ),使用量為0·1 mg/mL 〇 (2) T7基因1的選殖1230734 IX. Description of the invention: [Technical field to which the invention belongs] The present invention relates to a method for controlling gene tables and expression vectors in Escherichia coli with inducers. More specifically, the second invention is an induction with L-arabinose Control method for controlling the T7 expression system in a way 'This method is supplemented with a two-stage carbon source and a feed batch fermentation strategy for segmented feeding to achieve the purpose of mass production of recombinant protein. [Prior Art] Background of the Invention The production of recombinant proteins with commercial value or medical use from biological cells is an extremely important and economically prospective biotechnology industry. In general, biological cells that can be used as protein shells include microorganisms, insects, animals, and plant cells. Among them, the method of using microbial cells to produce recombinant proteins is more economically competitive, because microbial cells are more likely to be large in number. The nutrient matrix formulation required for culturing, rapid growth, and culturing is simple and inexpensive. In the past decades, as many scientific researches have used Escherichia coli as the core theme, the academic community has accumulated a large and detailed knowledge about the biochemistry of this species. No doubt, the development of E. coli to manufacture recombinant Protein production systems are also relatively more successful than systems developed using other biological cells. 1230734 For the purpose of using biological cells to effectively produce proteins, gene expression vectors are an indispensable weapon. There are many gene expression vectors developed in E. coli for different needs (Markides, Microbiol · Rev ·, 60: 512-538, 1996), among them, the most popular T7 expression system used in laboratories. The T7 expression system includes T7 RNA polymerase and one that can be polymerized by T7 RNA.酉 T7 promoter per drive. T7 RNA polymerisation is a product of phage T7 gene 1 (T7 gene 1). Compared to E. coli RNA polymerisation, it has extremely superior transcription capabilities for cloned genes. (Colomb and Chamberlin, J. Biol · Chem ·, 249: 2858-2863, 1974), and it is specific to the T7 promoter (Tabor and Richardson, Proc. Natl. Acad · Sci · USA, 82 : 1074-1078, 1985), based on the specific selectivity and superior transcription ability of T7 RNA polymerisation, Studier et al. (Studier and Moffatt, J. Mol. Biol. 189: 113-130, 1986; Studier et al., US patent 4,952,496, 1990) first developed the T7 expression system accordingly. This system contains a recombinant strain BL21 (DE3) and a gene expression plastid containing the T7 promoter, while the chromosome of the recombinant strain BL21 (DE3) contains a T7 gene controlled by the acUV5 promoter 1230734 at T7 In the expression system, although the method of slicing protein is extremely: it is easy to know that the production of the target substance is expensive and it is easy to know as 'however, the added chemical function of the protein is: and Γ yeast solution' is not conducive to the production of medical protein shellfish and cannot achieve uniform Induced per-cell. —The conventional technology is based on the production of a large amount of recombinant protein 化 galact〇pyran〇si / 3 丄) as a strict “material” gene expression plastids that enable bacteria to produce protein # 和 ”, MODE use There are important requirements ... that is, it has “infermentation regulations” and economical induction methods and high gene expression capabilities cannot reach 4%, and the Japanese t-type expression system is obviously used for industrial purposes. The reason is ⑴IPTG's shell '(2) | PTG is not metabolized by bacterial cells, but easily causes the fermentation broth to stain and makes the fermentation product difficult to purify' (3) IPTG is potentially toxic 'and therefore is not suitable for the production of medical products, ⑽' 52: 713-722, 1988), (4) Due to the insufficient regulation of the acUV5 promoter, the strain BL21 (DE3) produced a small amount of T7 RNA polymerization under non-induced conditions. The target gene product whose expression is controlled by the T7 promoter is thus produced, especially when the target gene product is potentially toxic to the host cell, the cell growth will be inhibited, and the plastid containing the target gene will be unstable (S tudier et al_, Methods in Enzymology, 185: 60-89, 1991) 'These shortcomings obviously limit the industrial applicability of the T7 expression system. 1230734 In another well-known technology, Wycuff and Mattews (Anal. Biochem., 277: 67-73, 2000), he developed the araBAD promoter to regulate the T7 gene 1, and then control the expression of target genes selected under the T7 promoter. . However, this conventional technique is to clone the T7 gene 1 regulated by the araBAD promoter on a plastid with a pACYCI 84 origin of replication, so it leads to excessively uninduced protein production and is not suitable for production. Potentially toxic recombinant protein. 1230734 [Summary of the Invention] Summary of the Invention Past research has found that the araSAD promoter, which can be induced by L-arabinose, has tight regulation, prompt activation and high-level expression. And other characteristics (Guzman et al., J. Bacteriol., 177: 4121-4130, 1995), so the present invention is particularly applied to the control of the T7 expression system with L-arabinose as an inducer. The main object of the present invention is to provide a method for controlling the T7 expression system in E. coli with an inducer in order to improve the T7 expression system and make it industrially applicable. Another object of the present invention is to use L-arabinose as an inducer to control the T7 expression system and cooperate with a two-stage carbon source and segmented feed fermentation strategy to achieve the mass production of recombinant protein by the strain. The present invention is to construct a recombinant strain BL21 (BAD) capable of inducing the production of T7 RNA polymerization using L-arabinose. The chromosome clamp of this strain contains the T7 gene 1 controlled by the ara ^ AD promoter and araC control. Gene (regulatory gene). Basically, the complex protein formed by the combination of AraC regulatory protein and L-arabinose can drive the activation of araS / \ D promoter, while AraC control protein 1230734 white matter itself has the ability to inhibit the araS / AD promoter, so recombination The production of strain T7 RNA aggregates depends on the presence or absence of L-arabinose, and the expression of target genes selected downstream of the T7 promoter is naturally controlled by L-arabinose. In a preferred embodiment of the present invention, taking the production of the carbamoylase protein of Agrobacterium radiobacter NRRL B11291 as an example, carbamoylase is scarcely produced in the strain BL21 (BAD) when it is not induced by the addition of L-arabinose. When L-arabinose is induced, the strain BL21 (BAD) produces carbamoylase up to 30% of the total cellular protein mass. This result shows that the system developed by the present invention has the potential for industrial fermentation to produce recombinant proteins. Fermentation with a high cell density feed batch and induction with a sufficient amount of L-arabinose, the strain BL21 (BAD) can produce more than 1000 times the amount of protein produced by shake flask fermentation. The "two-stage carbon source method" is applied throughout the entire feed batch fermentation step. Glucose is used in the initial fermentation stage to stabilize the recombinant plastids, while in the feed stage, a mixture of glucose and glycerol is used to induce efficiency and reduce costs. . In addition, in order to achieve the purpose of mass production of recombinant proteins, the present invention further develops the "segmented feeding method" at the feeding stage to achieve high cell density fermentation. Induced by the addition of an appropriate amount of L-arabinose or soybean extract, the strain BL21 (BAD) can produce more than 1,000 times the amount of protein produced by the flask-scale production of 1230734. In summary, the system developed by the present invention has the following advantages: (1) L-arabinose can be induced to produce recombinant proteins. The source of L-arabinose can be taken from plants such as soybean extract, which is not only economically competitive but also economically competitive. For bacterial metabolism and decomposition without causing contamination of fermentation broth. (2) The araBAD promoter is extremely sensitive. 10 # μ of L-arabinose can induce recombinant strains to produce large amounts of protein. (3) The strain BL21 (BAD) of the present invention is extremely stable and can maintain 100% stability of the ca "bam〇y | ase gene plastids to 100 cell generations, and the relative strain BL21 (DE3) Only the same plastid stability can be maintained for only 20 cell generations. (4) The "r-segment feed type" fermentation strategy developed by the present invention can culture the strain of the present invention at a fermentation tank scale to a high cell density, with a cell density of up to L 37. 5 9 dry weight cells. (5) The "two-stage carbon source method" strategy developed by the present invention can effectively maintain the stability of the recombinant plastids. The bacterial strains developed by the present invention are induced by 1-2% soybean extract, and the strains can be higher than the shake flask. Recombinant eggs with a scale of 10,000 times ^ 'This shows that the combination of the fermentation method developed by the present invention and the strain BL21 (BAD) constructed by the present invention can be used to mass-produce recombinant proteins, which has industrial practicality. 1230734 [Embodiment] Detailed description of the invention The method for controlling the T7 expression system by means of L-arabinose induction in the present invention includes the following steps: Construct a recombinant strain of the strain, the recombinant strain contains a 7 promoter And the chromosome of the recombinant strain contains the T7 gene 1 and arac control gene controlled by the 卩 promoter; the recombinant strain is cultured by a feed batch fermentation method, and the fermentation broth provided in the batch fermentation stage Contains glucose as a carbon source, and in the feeding stage, the feed liquid towel provided contains glycerin and carbohydrate as carbon sources to achieve high cell density fermentation; and after the cells reach-fixed high density, add humans containing L-arabin A sugar inducer 'causes the recombinant strain to produce a recombinant protein. The control method of the present invention further includes: the recombinant strain BL21 (BAD) induced by L-arabinose is produced, and a heterogeneous protein (hetero, ogous prôtejn) is produced in a shake flask scale, and the production of heterogeneous protein is selected here. The source protein line is used as the detection mode. Other aspects and advantages of the present invention will be disclosed in detail below with reference to the related drawings and the principle of the present invention through the illustration '. (1) Construction of recombinant strain BL21 (BAD) 12 1230734 In order to develop a T7 expression system controlled by L-arabinose, a recombinant strain was first constructed so that its chromosome contains a T7 gene regulated by the araBAD promoter. 1 and araC control genes. A. Selection of T7 gene 1 (1) The strain used for gene selection and the shake flask culture method used E. coli DH5a (deoR endA1 g yr96 hsdR17 supE444 thi △ ( lacIZYA-argF 169) rec A1 lacZM15), when culturing bacteria in liquid state, first take a few colonies from a solid culture solitary midpoint into a nutrient-based shake flask, and spin in a water bath at 37 ° C, 200 rpm Cultivate overnight in a culture tank, take out the bacterial solution in a 100-fold dilution volume every other day and inoculate it into a shake flask containing fresh nutrient substrate, and continue to cultivate according to the same culture conditions. The composition of the nutrient substrate is determined by the requirements. Bertani (LB) was cultured underneath. The antibiotics were also added to the medium as needed. In this case, the antibiotic ampicillin was added in an amount of 0.1 mg / mL. (2) Selection of T7 gene 1

根據Τ7基因1的發表序列(Grachev and Pletnev, Bio org. Chem., 1 0:824-843,1984),我們設計一組涵蓋 T7 基因1編碼區(coding region)但排除啟動子區域的寡 核苦 S曼,其序列如下- CGGAATTCCCAACCGCGTGGCA 13 1230734 CAAC 和 CCGGATCCTCGAGCTAACTCACATTAATTG C,並委由 GENSET Singapore Biotech 公司合成。相 關選殖技術均參照 Maniatis et al.,Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laborat ory Press, Cold Spring Harbor, N.Y. (1982)—書。以 含 T7 基因 1 的質體 pMR_7wt ( Mallet et al·, Gene, 1 99:149-156,1997)為 DNA 樣版(DNA template),依 照一反應條件使用 PCR( polymerase chain reaction, 聚合酉每連鎖反應)反應來擴增製造2.7 kb的T7基 因1 DNA產物,其中此反應條件係為:50# L反應溶 液中包含樣板DNA(10 ng/mL)、2_5活性單元Pfu聚合 酉每、一對寡核苷酸(oligonucleotide) (0·5//M)和四種 核苷酸(200// M),首先將反應溶液加熱至94°C 3分鐘, 隨後以底下條件重複28循環:以94°C加熱1分鐘、55 °C4分鐘、72°C1分鐘,所有循環結束後再以72t維持 加熱10分鐘。 隨後將PCR產物以核苷酸純化組(NuceloSpin Nucl eic Acid Purification Kit, Clontech Lab., Inc·)純 化,並利用EcoRI、Hindi丨丨限制酵素切割和再純化,最 後使用T4 DNA粘接酉每(T4 DNA ligase)將DNA產物 點接至質體 pKF2 (Hashimoto-Gotoh et al.,Gene,1 37:211-216,1993)中。接著使用 Ec〇m、Hindlll 限制酵 1230734 素把含有T7基因1的DNA片段切下回收,再粘接至質 體 pBAD18 (Guzman et al_, J. Bacteriol., 177:4121 •4130,1995)。隨後使用Cla卜HindiII限制酵素將含有a raC基因和選殖於araBAD啟動子下游的T7基因1之D ΝΑ片段切割,並粘接至質體pACYC177得到質體pACY C-G1或pACYC184得到質體pACYC-G2。選殖在質體p ACYC-G1或pACYC-G2上的T7基因1位於araBAD啟 動子下游,而接鄰在啟動子的上游區則含有araC基因。 · B.選殖基因片段鑲箝入菌種染色體 (1)嗟菌體P1因子轉移法(P1 transduction) 以内含LB和5 mM氣化鈣營養基的搖瓶培養基因供給細 胞(donor cell),待細胞生長至OD55Q (波長550 nm吸 光度)達0.3時,加入濃度約每毫升108個P1vir噬菌體 分解顆粒(phage lysate),繼續培養直至細胞完全分解 ® 為止,將分解液回收並加入0.1 mL的氣仿,以4500 g , 離心1 0分鐘並回收上層液。另一方面,以内含LB營養 基的搖瓶過夜培養基因接收細胞(recipient cell),以150 00 g離心十分鐘回收細胞,隨即以2.5 mL濃度為10 mM的硫酸鎂和5 mM氣化鈣重新溶解回收細胞。取出Ο-ΐ mL 的菌 液放入試管中 ,並加 入等量體積的分解液 ,在 37°C下反應30分鐘,最後加入0.1 mL濃度為1 Μ的 15 1230734 檸檬酸鈉,由試管中取出0.1 mL的混合液灑養在篩選培 養基上。 (2)重組菌種建構 為了將選殖基因片段鑲箝入菌種染色體中,隨即由質體P ACYC-G1將含有位於araBAD啟動子下游的T7基因1 和上游區的araC基因之DNA片段以HindlH、Xhol限制 酵素切除並回收,最後插接入質體pBRINT-Cm (Baibas et al.,Gene, 172:65-69,1996)所含的 lacZ 基因當中 得到質體PBRINT-G1。接著把質體pBRINT-G1轉殖入 以氯化鈣處理的菌種JC7623 (recBC sbcBC)中,其質 體轉殖程序乃採用氯化妈製備升任細胞(competent ce 丨丨)法,相關技術主要參照Maniatis et al_,Molecular C loning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. (1982) 一書。 矛1J 用 lacZ 同源、基因重、组(homologous recombinat ion)方式將質體上的基因箝入菌種染色體中,轉植後的 菌種隨即麗養在含0_005 mg/mL氣黴素(chloramphenic 〇1)和 0.004% 5-bromo-4-chloro_3-indoly卜/5 -D_galacto -pyranoside(X-gal)的洋菜培養基上。其中一個呈現白色 的菌落以搖瓶培養作為噬菌體P1因子轉移法的基因供 16 1230734 給細胞,依據B的第(1)項方法製備分解液並感染基因接 收細胞大腸桿菌BL21,經基因轉移後的細胞則灑養在含 0.005mg/mL氣黴素和〇·〇〇4% X_ga丨的洋菜培養基上, 選擇一株顯現白色的細胞再利用pCR方法來檢視其染色 體上是否含有T7基因1,如此得到的菌種便命名為BL2 1(BAD)。 C二)、以菌種BL21(BAD)進行搖瓶規模的檢測模式 檢驗重組菌種BL21 (BAD)產生異源重組蛋白質的可 行性,在此我們選擇生產carbam〇y|ase為檢測模式。生 產異源蛋白質(heterol〇gOUS protein)最大的挑戰莫過 於σ玄蛋白貝易形成内涵體(inclusion body )和具有毒宝 細胞的特性,而carbam〇y丨ase來自A 「a⑴〇(^以8「是 屬於異源蛋白質’況且極易形成内涵體和潛在毒性,因 此X此蛋白貝作為生產模式正足以對本發明建構的系統 提供最嚴苛的檢測方式。 Α·培養方法與營養基質 與建構重組菌種BL21(BAD)中Α項培養方法相同,使用 搖瓶來養菌種。S_M9基質配方包含每升^ 9碌酸化 二鈉、3/魏鉀、Q5 g氣化納、]g氣化氨、〇〇 1 _氣化轉、1 _硫化鎖、1 mg維他命B1和5 1230734 g酵母萃取。 B. Carbamoylase酵素活性分析Based on the published sequence of T7 gene 1 (Grachev and Pletnev, Bio org. Chem., 1 0: 824-843, 1984), we design a set of oligos that cover the coding region of T7 gene 1 but exclude the promoter region Ku Sman, its sequence is as follows-CGGAATTCCCAACCGCGTGGCA 13 1230734 CAAC and CCGGATCCTCGAGCTAACTCACATTAATTG C, and commissioned by GENSET Singapore Biotech company. Relevant breeding techniques are referred to Maniatis et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laborat ory Press, Cold Spring Harbor, N.Y. (1982) —Book. The pMR_7wt (Mallet et al., Gene, 1 99: 149-156, 1997) plastid containing T7 gene 1 was used as a DNA template, and polymerase chain reaction (PCR) was used according to a reaction condition. Reaction) reaction to amplify and produce a 2.7 kb T7 gene 1 DNA product, where the reaction conditions are: 50 # L reaction solution contains template DNA (10 ng / mL), 2_5 active unit Pfu polymerization, each pair of oligo For oligonucleotide (0.5 // M) and four nucleotides (200 // M), first heat the reaction solution to 94 ° C for 3 minutes, then repeat 28 cycles under the following conditions: at 94 ° C heating for 1 minute, 55 ° C for 4 minutes, and 72 ° C for 1 minute. After all the cycles are completed, the heating is maintained at 72t for 10 minutes. The PCR products were subsequently purified using a NucleoSpin Nucl eic Acid Purification Kit (Clontech Lab., Inc.), and EcoRI and Hindi were used for restriction enzyme cleavage and re-purification. Finally, T4 DNA was used to bind each ( T4 DNA ligase) spots the DNA product into pKF2 (Hashimoto-Gotoh et al., Gene, 1 37: 211-216, 1993). Then, using Ecomm and Hindlll restriction enzyme 1230734, the DNA fragment containing T7 gene 1 was cut and recovered, and then bonded to pBAD18 (Guzman et al., J. Bacteriol., 177: 4121 • 4130, 1995). Subsequently, Cla and HindiII restriction enzymes were used to cut the D ΝA fragment containing a raC gene and T7 gene 1 selected downstream of the araBAD promoter, and then bonded to plastid pACYC177 to obtain plastid pACY C-G1 or pACYC184 to obtain pACYC. -G2. The T7 gene 1 selected for plastid p ACYC-G1 or pACYC-G2 is located downstream of the araBAD promoter, and the upstream region of the promoter contains the araC gene. · B. Selective gene fragments are clamped into the chromosome of the strain (1) P1 factor transduction (P1 transduction). Shaker cultured donor cells containing LB and 5 mM calcium gasified nutrients. When the cells grow to OD55Q (wavelength 550 nm absorbance) reaches 0.3, add about 108 P1vir phage lysate per milliliter, continue to culture until the cells are completely degraded ®, recover the decomposition solution and add 0.1 mL of air Centrifuge at 4500 g for 10 minutes and recover the supernatant. On the other hand, the gene receiving cells were cultured overnight in a shake flask containing LB nutrient base. The cells were recovered by centrifugation at 150 00 g for ten minutes, and then re-reconstituted with 2.5 mL of 10 mM magnesium sulfate and 5 mM calcium carbonate. Lyse the recovered cells. Take out 0-ΐ mL of the bacterial solution into a test tube, add an equal volume of the decomposition solution, react at 37 ° C for 30 minutes, and finally add 0.1 mL of 15 1230734 sodium citrate with a concentration of 1 M, and remove it from the test tube 0.1 mL of the mixed solution was sprinkled on the selection medium. (2) Recombinant strain construction In order to clamp the selection gene fragment into the strain chromosome, the DNA fragment containing the T7 gene 1 downstream of the araBAD promoter and the araC gene upstream of the araBAD promoter was replaced by plastid P ACYC-G1. HindlH and Xhol restriction enzymes were excised and recovered, and finally inserted into plastid pBRINT-Cm (Baibas et al., Gene, 172: 65-69, 1996) to obtain plastid PBRINT-G1. Then, pBRINT-G1 was transformed into calcium chloride-treated strain JC7623 (recBC sbcBC). The procedure for plastid transformation was to use the method of preparing elevated cells (competent ce 丨 丨). With reference to Maniatis et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1982). The spear 1J clamped the gene on the plastid into the chromosome of the strain using homologous, gene weight, and homologous recombination methods. The transformed strain was then cultured in a chloramphenic solution containing 0_005 mg / mL 〇1) and 0.004% 5-bromo-4-chloro_3-indoly Bu / 5 -D_galacto-pyranoside (X-gal) on agar culture medium. One of the white colonies was cultured in shake flasks as a gene for the phage P1 factor transfer method. 16 1230734 was given to the cells. The decomposition solution was prepared according to the method (1) of B and the gene-receiving cell E. coli BL21 was infected. The cells were sprinkled on a broth containing 0.005mg / mL aeromycin and 0.004% X_ga 丨, and a white-colored cell was selected and the pCR method was used to check whether the chromosome contained the T7 gene1. The strain thus obtained was named BL2 1 (BAD). C). Shake flask-scale detection mode using strain BL21 (BAD) To test the feasibility of recombinant strain BL21 (BAD) to produce heterologous recombinant protein, we choose to produce carbamoyase as the detection mode. The biggest challenge in producing heterologous protein is that σ protein can easily form an inclusion body and possess the characteristics of poisonous cells, while carbam〇yase is derived from A "a⑴〇 (^ 8 "It is a heterologous protein" and it is easy to form endosomes and potential toxicity. Therefore, as a production mode, this protein shell is sufficient to provide the most rigorous detection method for the system constructed by the present invention. Α · Cultivation method and nutrition matrix and construction recombination The culture method of item A in the strain BL21 (BAD) is the same, and the shake flask is used to cultivate the bacteria. The S_M9 matrix formula contains 9 sodium persulfate per liter, 3 / potassium potassium, Q5 g gas sodium, and g gas ammonia. , 〇〇1 _ gasification conversion, 1 _ sulfur lock, 1 mg of vitamin B1 and 5 1230734 g yeast extract. B. Carbamoylase enzyme activity analysis

Carbamoylase酵素活性分析主要依據過去已發表的方 法(Chao et al_,Biotechnol. Prog., 15:603-607, 199 9),而一個單位酵素活性(U)定義為每分鐘一毫莫耳產 物生成,比酵素活性單位為U/mg乾重細胞,體積酵素活 性則以測得的比酵素活性與獲得的細胞濃度之乘積所 得,單位為U/mL。 C. 蛋白質電泳膠分析 主要依據過去發表的方法(Chao and Liao, J. Biol· C hem., 269:5122-5126, 1994)操作,將離心收集到的細 胞用法式細胞粉碎機(French Press)打破,以15000 g離心5分鐘後回收上層液,使用Bradford分析法(Bio-Rad) 量測蛋白質濃度,將 20 mg 的蛋白質樣本逐一置入 電泳膠中。 D. 左旋阿拉伯糖誘導生產重組蛋白質之特性 將含有以T7啟動子調控carbamoylase基因表達的質體 pTAHLIO (Chao et al·,Appl. Microbiol. Biotechnol., 1230734 54:348-353 (2000))和含有以araBAD啟動子調控gro ELS基因表達的質體pAR3-GR〇-Km同時轉殖到菌種B L21(BAD)中,得到重組菌種 BL21(BAD)/pTAHL10/pAR3 -GR〇-Km。質體 pAR3-GRO-Km 源自於質體 pAR3-GR 〇(Perez and Gutierrez, Gene, 158:141-142,1995), 一個抗卡那黴素的基因片段由質體pKRP11 (Reeceand Philip, Gene, 165:141-142,1995)以 EcoRI 限制酵素 切下回收,隨即粘接入質體pAR3-GR〇得到質體pAR3- # GR〇-Km。首先以不同營養基質並使用搖瓶方式培養重 組菌,待細胞生長至〇D55〇達0.5時,加入300 // Μ左 旋阿拉伯糖,隨後繼續培養細胞至停滯生長時期,以15 000 g離心10分鐘回收細胞並測定酵素活性,結果整理 在表一。 相較於非誘導菌種而言,以左旋阿拉伯糖誘導的菌 種可產生50-100倍可溶性carbamoylase。而營養基中 ® 含有葡萄糖可有效降低非誘導時蛋白質生成量,但即加 〃 入左旋阿拉伯糖卻也難以誘導產生大量重組蛋白質,這 是由於araBAD啟動子會受到基質抑制(substrate inhi bition )效應所造成的結果。另一方面,非誘導時生產的 蛋白質量在較豐富的營養基如LB中也較高,其中我們發 現LB營養基中所含的胰化胨(tryptone)是造成高非誘導 時蛋白質生成量的主因。這些結果顯示,本發明發展的 19 1230734 菌種卻可利用左旋阿拉伯糖誘導方式來控制T7表達系 統以生產重組蛋白質,且具有嚴密調控和高蛋白質生產 之效能。 由表一可知,本發明發展的菌種可藉由左旋阿拉伯 糖來誘導生產重組蛋白質,而不同濃度的左旋阿拉伯糖 將景^響菌種蛋白質生產量。因此,重組菌種BL21 (BAD), PTAHL1〇/PAR3_GR〇-Km以LB為營養基以搖瓶在3rc 條件下培養,待細胞生長至〇〇55〇達〇 5時,加入不同 濃度的左旋阿拉伯糖,隨後繼續培養細胞至停滞生長時 期,以15000 g離心1〇分鐘回收細胞並測定酵素活性 如圖一 (a)所示,菌種生成的蛋白質量隨著左旋阿拉伯糖 $誘導濃度增加而增加,當濃度達3〇〇/zM時蛋白質產 量達到飽和。參考圖一(b)的蛋白質電泳分析,其中徑、】: 蛋白質標準物;徑2 :未經誘導;徑3 :以1〇/z Μ左旋 阿拉伯糖誘導;徑4 : Μ左旋阿拉伯糖誘導;徑 5 :以50# Μ左旋阿拉伯糖誘導;徑6 :以i〇〇y μ左旋 阿拉伯糖誘導;徑7 :以3〇〇“ Μ左旋阿拉伯糖誘導;徑 8首:以2000_左旋阿拉伯糖誘導。左旋阿拉伯糖的誘 ‘以蛋白質電泳分析並佐以影像分析(GAS9000,UVltec ^UK)可。定量出最A可溶性蛋白質量達到總細胞蛋白質 =的3〇/° ,而微量的左旋阿拉伯糖如1 ο # Μ即可誘導 菌種生產出相當於鄉的總細胞蛋白質。這些結果顯示 本發明發展的表達系統具有優越的蛋白質生產效能和高 20 1230734 敏感之特性。 E.重組菌種質體穩定度測試 重組菌種 BL21(BAD)/pTAHL10/pAR3-GRO-Km 以内含 2 0 mL未含抗生素營養基質之搖瓶在37°C、每分鐘200 轉條件下培養過夜,取出0.2 mL菌液接種至另一個含有 20 mL新鮮基質之搖瓶,依相同條件繼續培養至隔日, 即完成一個培養循環。在每一培養循環終止時,取出〇. 1 mL樣本並注入含1 mL的無菌生理食鹽水的試管中, 如此經過一系列連續稀釋後,取出0.1 mL樣本灑養在洋 菜培養基,於30°C下培養16小時後,再挑選1〇〇顆菌 落分別點劃在一個洋菜培養基和另一個含抗生素的洋菜 培洋基上,於30°C下培養16小時後,估計每一個培養 基生成的菌落數,而質體穩定度即定義成在含有抗生素 的洋菜培洋基上之菌落數除以在洋菜培養基形成之菌落 數。相同培養循環則依需要持續進行到終止,而每一培 養循環估計約經過10個細胞世代。同樣的,我們將質體 pTAHLIO和pAR3-GR〇-Km同時轉殖到過去發明所發 展的菌種BL21(DE3)中得到重組菌BL21(DE3)/pTAHL1 0/pAR3-GR〇-Km,並依照上述方式測試菌種bL21(DE3) 對於質體的穩定性。 結果如表二顯示,在所測試的營養基質中菌種BL21 1230734 (BAD)可以維持100〇/〇的質體穩定度達1〇〇細胞世代,而 菌種BL21(DE3)在LB營養基下經過50細胞世代只維持 50%的質體穩定度,在s_M9營養基下經過50細胞世代 只維持68%的質體穩定度,由此可知本發明發展之菌種 BL21 (BAD)具有極高的質體穩定性。 (三)、以饋料批次發酵培養BL21 (BAD)達到高細胞密度 一個基因表達系統的實用性決定在放大規模時仍具可行 性,除此之外,在工業化量產重組蛋白質時,高蛋白質 的產量乃是必然的考量,而其成功的關鍵則在於重組菌 種發酵誘導後能同時獲得高細胞密度和高酵素比活性。 基於此,本發明在饋料批次發酵的進料階段,首先發展 所謂的「區段式進料法」以達高細胞密度培養的目的。 A·區段式進料法 饋料批次發酵法是培養高細胞密度最佳的方法,其基本 理論在於利用進料量來控制細胞比生長速率,以使得菌 種無法或是降低製造發酵產物如酸等。本發 區段式進料法乃將進料區分成i個區段(i = 個進料區段以定流速F進料以分鐘 :義: 得程式⑴’細胞比生長速率定義得到程式 22 1230734 (1) (2)可‘出程式(3)。程式(3)說明在欲控制的細胞比 生長速率和生長率條件下,可以計算出每個區段的進料 流量。 (1) (2) (3) Y = (Vi Xi . \/i-1 Xj-1)/(F At S) d(Vi Xi)/dt = u (Vi Xi) F = {Vi-1 Xi^i [exp(//At) - 1]}/(YSAt) F ·進料流量(mL/min ) S :進料濃度(mg/mL) ® △t :階段進料時間(min) m :比生長速率( V :發酵槽體積(mL) 丫一 AX/^S :生長率(mg/mg) X ··細胞濃度(mg/mL)Carbamoylase enzyme activity analysis is mainly based on previously published methods (Chao et al_, Biotechnol. Prog., 15: 603-607, 199 9), and a unit enzyme activity (U) is defined as one millimolar product per minute, The specific enzyme activity unit is U / mg dry weight cells, and the volume enzyme activity is obtained by the product of the measured specific enzyme activity and the obtained cell concentration, and the unit is U / mL. C. The analysis of protein electrophoresis gel is mainly based on the method published in the past (Chao and Liao, J. Biol · C hem., 269: 5122-5126, 1994). The cells collected by centrifugation are processed with a French Press. After breaking, centrifuge at 15000 g for 5 minutes, recover the supernatant, and use Bradford analysis (Bio-Rad) to measure the protein concentration. Put 20 mg of protein samples into the electrophoresis gel one by one. D. L-arabinose-induced production of recombinant proteins will contain pTAHLIO (Chao et al., Appl. Microbiol. Biotechnol., 1230734 54: 348-353 (2000)), a plastid that regulates carbamoylase gene expression with the T7 promoter and PAR3-GR0-Km, a plastid that regulates gro ELS gene expression with the araBAD promoter, was simultaneously transfected into strain B L21 (BAD) to obtain recombinant strain BL21 (BAD) / pTAHL10 / pAR3-GR0-Km. The plastid pAR3-GRO-Km is derived from pAR3-GR 〇 (Perez and Gutierrez, Gene, 158: 141-142, 1995). A kanamycin-resistant gene fragment is composed of pKRP11 (Reeceand Philip, Gene , 165: 141-142, 1995) was cut with EcoRI restriction enzyme and recovered, and then adhered into plastid pAR3-GR0 to obtain plastid pAR3- # GR0-Km. First, culture the recombinant bacteria with different nutrient substrates and shake flasks. When the cells grow to 0D55 and 0.5, add 300 // M-L-arabinose, and then continue to culture the cells to the stage of stagnant growth. Centrifuge at 15 000 g for 10 minutes. The cells were recovered and the enzyme activity was measured. The results are summarized in Table 1. Compared with non-inducing strains, strains induced with L-arabinose can produce 50-100 times more soluble carbamoylase. Containing glucose in the nutrient base can effectively reduce the amount of protein produced during non-induction, but it is difficult to induce the production of a large amount of recombinant protein even with the addition of L-arabinose. This is because the araBAD promoter is subject to a substrate inhi bition effect. The result. On the other hand, the quality of proteins produced during non-induction is also higher in richer nutrient bases such as LB. Among them, we have found that tryptone contained in LB nutrient bases causes high protein production during non-induction. The main cause. These results show that the 19 1230734 strain developed by the present invention can use the L-arabinose induction method to control the T7 expression system to produce recombinant proteins, and has the effect of tight regulation and high protein production. As can be seen from Table 1, the strains developed by the present invention can induce the production of recombinant protein by using L-arabinose, and different concentrations of L-arabinose will produce the amount of protein produced by the bacteria. Therefore, recombinant strains BL21 (BAD), PTAHL1〇 / PAR3_GR0-Km were cultured in shake flasks at 3rc with LB as the nutrient base. When the cells grew to 0.055 and reached 0.5, add different concentrations of L-arabin Sugar, and then continue to culture the cells to the stage of stagnant growth. Centrifuge at 15,000 g for 10 minutes to recover the cells and determine the enzyme activity. As shown in Figure 1 (a), the amount of protein produced by the strain increases with the increase in the concentration of L-arabinose $. When the concentration reached 300 / zM, the protein yield reached saturation. Refer to Figure 1 (b) for protein electrophoresis analysis, where: []: protein standard; diameter 2: uninduced; diameter 3: induced with 10 / zM-L-arabinose; diameter 4: induced by M-L-arabinose; Path 5: Induced by 50 # Μ L-arabinose; Path 6: Induced by 100μ μ L-arabinose; Path 7: Induced by 300 ′ Μ L-arabinose; Path 8: 2000_L-arabinose Induction. L-arabinose can be induced by protein electrophoresis analysis and image analysis (GAS9000, UVltec ^ UK). The most soluble protein can be quantified to reach 30 / ° of total cell protein =, and a small amount of L-arabinose Such as 1 ο # Μ can induce the strain to produce total cellular protein equivalent to the township. These results show that the expression system developed by the present invention has superior protein production efficiency and high sensitivity of 20 1230734. E. Recombinant bacterial plastids Stability test: Recombinant strain BL21 (BAD) / pTAHL10 / pAR3-GRO-Km contains 20 mL shake flasks without antibiotic nutrient matrix and cultured at 37 ° C, 200 rpm overnight, and 0.2 mL of bacterial solution is removed. Inoculate to another containing In a 20 mL shaker flask with fresh substrate, continue to cultivate the next day under the same conditions to complete a culture cycle. At the end of each culture cycle, take a 0.1 mL sample and inject it into a test tube containing 1 mL of sterile physiological saline. After a series of serial dilutions in this manner, take out a 0.1 mL sample and sprinkle it on the agar culture medium. After incubating at 30 ° C for 16 hours, select 100 colonies to mark one agar culture medium and another antibiotic-containing culture medium. The number of colonies produced on each medium after incubation at 30 ° C for 16 hours on agar-pepper Yankee, and plastid stability is defined as the number of colonies on the agar-pepper Yankee containing antibiotics divided by the number of The number of colonies formed in the culture medium. The same culture cycle is continued as necessary to the end, and each culture cycle is estimated to pass about 10 cell generations. Similarly, we plastid pTAHLIO and pAR3-GR0-Km were simultaneously transplanted to the past The recombinant strain BL21 (DE3) / pTAHL1 0 / pAR3-GR0-Km was obtained from the strain BL21 (DE3) developed by the invention, and the stability of the strain bL21 (DE3) to the plastid was tested in the manner described above. The results are shown in the table. two It was shown that the strain BL21 1230734 (BAD) can maintain a plastid stability of 100/0 for 100 cell generations in the tested nutrient matrix, and the strain BL21 (DE3) has passed 50 cell generations under the LB nutrient base. Only 50% of plastid stability is maintained, and only 50% of plastid stability is maintained after 50 cell generations under the s_M9 nutrient base. It can be seen that the strain BL21 (BAD) developed by the present invention has extremely high plastid stability . (3) Fermentation of BL21 (BAD) by feed batch fermentation to achieve high cell density. The practicality of a gene expression system is still feasible when scaling up. In addition, when industrialized mass production of recombinant proteins, high The yield of protein is an inevitable consideration, and the key to its success is that it can obtain high cell density and high enzyme specific activity at the same time after the fermentation of recombinant strains is induced. Based on this, in the feeding stage of the feed batch fermentation, the present invention first develops the so-called "segmented feeding method" to achieve the purpose of high cell density culture. A · Segmented feeding method. The batch fermentation method is the best method for culturing high cell density. The basic theory is to use the amount of feed to control the specific cell growth rate, so that the bacteria cannot or can reduce the production of fermentation products. Such as acid. The section feeding method of the present invention is to divide the feeding into i sections (i = feeding sections at a constant flow rate F to feed in minutes: meaning: get formula ⑴ 'cell specific growth rate definition to get formula 22 1230734 (1) (2) The formula (3) can be used. The formula (3) shows that under the conditions of the specific cell growth rate and growth rate to be controlled, the feed flow of each section can be calculated. (1) (2) ) (3) Y = (Vi Xi. \ / I-1 Xj-1) / (F At S) d (Vi Xi) / dt = u (Vi Xi) F = (Vi-1 Xi ^ i [exp ( // At)-1]} / (YSAt) F · Feed flow rate (mL / min) S: Feed concentration (mg / mL) ® △ t: Stage feed time (min) m: Specific growth rate (V : Fermentation tank volume (mL) Ya-AX / ^ S: Growth rate (mg / mg) X ·· Cell concentration (mg / mL)

Vi_1、Vi :第i區段起始體積和最終體積Vi_1, Vi: starting volume and final volume of the i-th segment

Xi-1、Xi ·第i區段起始細胞濃度和最終鈿胞濃度 _ B ·高細胞密度培養Xi-1, Xi · Initial cell concentration and final cell concentration in section i _ B · High cell density culture

採用5 L實驗室規模的發酵槽(Bj0Stat,β· Braun Ger many)作為放大規模菌種的培養。發酵槽操作的條件設定 在37°C、pH 6.5-7.0、溶氧度為15%的飽和溶氧度。先 期以搖瓶培養 300 mL 的 BL21(BAD)/pTAHL1〇/pAR3-G 23 1230734 R〇"Km菌種作為接種菌(實例- A項),而營養基質為s =上〇·2%葡萄糖,待細胞培養至⑽咖達巧時,將 斤=菌液接種至含15 L營養基的發酵槽中,而發酵槽 1培養基成分為每升溶液含3·3 g磷酸鉀、15·3 g磷 ,化二鉀、3 46 9氣化氨、〇·19 g硫酸鎂、〇·12 / l化鐵〇.的9氣化|弓、〇·〇3 mg維他命Β1、5 g 酵母萃取和115 g葡萄糖。當細胞在批次發酵階段生長 ,入停滯生長期,Q_5 L的進料液隨即以A項程式(似 疋的机速使用幫浦打人發酵槽中直到進料結束。而 液的營養基質成分為每升溶液含6 g氯化氨 硫化鐵、20 g酵母萃取和300 g = 、 圖一所不,在批次發酵結束後隨即以區段式方 進料’最後發酵結果可得到總細胞乾重達75g。 /A 5 L laboratory-scale fermentation tank (Bj0Stat, β · Braun Ger many) was used for the cultivation of scale-up strains. The conditions for the operation of the fermentation tank were set at 37 ° C, pH 6.5-7.0, and saturated oxygen at 15%. 300 mL of BL21 (BAD) / pTAHL1〇 / pAR3-G 23 1230734 R〇 " Km strain was used as inoculum (Example-item A), and the nutrient matrix was s = 0.2% glucose , When the cells are cultured to the end of the coffee, inoculation of jin = bacterial solution into a fermentation tank containing 15 L of nutrients, and the fermentation tank 1 medium composition contains 3 · 3 g potassium phosphate, 15 · 3 g per liter of solution Phosphorus, dipotassium, 3 46 9 gasified ammonia, 0.19 g of magnesium sulfate, 0.12 / l of iron gasified by 9 gasification | bow, 0.03 mg of vitamin B1, 5 g of yeast extract and 115 g glucose. When the cells grow in the batch fermentation stage and enter the stagnant growth stage, the feed liquid of Q_5 L will then use the A program (similar to the speed of the pump to use the pump to enter the fermentation tank until the end of the feed. The nutrient matrix component of the liquid For each liter of solution containing 6 g of ferric chloride ammonium sulfide, 20 g of yeast extract, and 300 g =, as shown in Figure 1, after the batch fermentation is completed, it will be fed in a segmented method. The final fermentation result can obtain the total cell stem. Weighs 75g. /

BL21(BA 四卩左&阿拉伯糖誘導高細胞密度的菌種 D)生產發酵槽規模的重組蛋白質 ^月的=料批次發酵係應用「二階段碳源方式」以 源阿:度發—酵。在批次發酵階段採用葡萄糖作為 :改;重組菌種中的質體,而在區段進料發酵階我 =採Γ糖和甘油混合物為碳源,以期-方面;: =拉;6糖誘導一敗動子以促進大量重組蛋 方面則考量降低發酵成本。 24 1230734 A. 階段碳源方式與區段式進料法進行高細胞密度發酵 採用5 L實驗室規模的發酵槽(B丨〇賊b細,⑽ many。)作為放大規模_的培養。發酵槽操作的條件設定BL21 (BA Si-Left & Arabinose-Induced High Cell Density D) Produces fermenter-scale recombinant proteins. Monthly = batch batch fermentation system applies "two-stage carbon source method" to source A: Dufa— yeast. In the batch fermentation stage, glucose is used as: modified; the plastids in the recombinant strains, and in the section feed fermentation stage I = picking a mixture of Γ sugar and glycerin as a carbon source, with a view to-aspects; = = pull; 6 sugar induction One failure to promote a large number of recombinant eggs is to reduce fermentation costs. 24 1230734 A. High-cell-density fermentation by stage carbon source method and segmented feed method A 5 L laboratory scale fermentation tank (B, 0, 细, ⑽, 作为 many.) Was used as a large-scale culture. Setting conditions for fermentation tank operation

C PH 6.5 7.0、溶氧度為π%的飽和溶氧度。先 期以搖瓶培養 300 mL 的 BL21(BAD)/pTAHLl〇/_3 G RO-Km菌種作為接種菌(實例一八項),而營養基質為$ -M9加上〇.2〇/0葡萄糖,待細胞培養至〇d5如達】時,將 所^菌液接種至含1·5 L營養基的發酵槽中,而發酵槽 中培養基成分為每升溶液含3.3 g磷酸鉀、15 3 g鱗 ,化二鉀、3.46 g氯化氨、0.19 g硫酸鎂、〇 12 g牛 石瓜化鐵、〇.09 g氯化約、0.03 mg維他命B1、5 g 酵母萃取和11.5 g葡萄糖。#細胞在批次發酵階段生長 進入帶生長期’ 1 L的進料液隨即以程式(3)決定的流 速使用幫浦打入發酵槽中直到進料結束。而進料液的營 養基質成分為每升溶液含12 g氣化氨、14 g硫酸鎂、 〇_2g硫化鐵、4〇 g酵母萃取、1〇〇g葡萄糖和扣 〇 g甘油。在整個發酵過程中所使用的培養液均排除使 用抗生素。 B_以微量左旋阿拉伯糖誘導大量的重組蛋白質 25 1230734 在上述重組菌種 BL21 (BAD)/pTAHL1 0/pAR3-GR〇-Km 進行饋料批次發酵的進料階段末期以左旋阿拉伯糖進行 誘導。在細胞密度為每升18g乾重細胞時,以每升“左 旋阿拉伯糖誘導,另一方面考量降低發酵成本,左旋阿 拉伯糖含量豐富的植物萃取液如大豆萃取液亦被用來作 為誘導物。另外由圖二的發酵曲線選擇適當誘導時機如 區段進料後10小時或16小時。結果得到在誘導條件為 區段進料後10小時或彳6小時,以推算的左旋阿拉伯糖 為誘導飽和量或是0.10.2%的大豆萃取液來誘導,發酵 培養的細胞密度可達每升約35g乾重細胞,而酵素體積 活性達2.92 U/mL。整個發酵產生的重組蛋白質總計有8 760 U,這個產量是以搖瓶方式所獲得蛋白質量的1〇〇〇 ^ 此外,在發酵結束後檢測菌種所含質體之穩定度也 達100% 。這些結果顯示,本發明發展的菌種具有高穩 定性且可放大生產大量的重組蛋白質,極有工業實用I 力。 發明功效 根據本發明所實施以左旋阿拉伯糖誘導方式來控制 T7表達系統的控制方法,只需微量的左旋阿拉伯糖或是 採用價格低廉的植物萃取液如大豆萃取液即可達到誘導 生產大量的重組蛋白質之效能,特具經濟效益。此外, 為有效利用本發明的菌種以達工業量產重組蛋白質之目 26 1230734 的,本發明發展高細胞密度發酵策略,成功的將重組蛋 白質以發酵規模大量生產,其產量超出搖瓶規模產量的1 000 倍。C PH 6.5 7.0, saturated oxygen with a dissolved oxygen of π%. 300 mL of BL21 (BAD) / pTAHL10 / _3 G RO-Km strain was used as inoculum in the previous flask culture (Example 18 items), and the nutrient matrix was $ -M9 plus 0.20 / 0 glucose. When the cells are cultured to 0 d5, the bacterial solution is inoculated into a fermentation tank containing 1.5 L of nutrients, and the medium in the fermentation tank contains 3.3 g potassium phosphate per liter of solution, 15 3 g scales , Dipotassium, 3.46 g of ammonia chloride, 0.19 g of magnesium sulfate, 012 g of iron taurine, 0.09 g of chloride, 0.03 mg of vitamin B1, 5 g of yeast extract, and 11.5 g of glucose. #Cells grow in the batch fermentation stage. Into the growth stage ’1 L of feed solution is then pumped into the fermentation tank at the flow rate determined by formula (3) until the end of the feed. The nutrient matrix components of the feed solution contained 12 g of gasified ammonia, 14 g of magnesium sulfate, 0 g of iron sulfide, 40 g of yeast extract, 100 g of glucose, and 0 g of glycerol per liter of solution. The broth used throughout the fermentation process excludes the use of antibiotics. B_ Induction of a large amount of recombinant protein with a trace amount of L-arabinose 25 1230734 Induction of L-arabinose at the end of the feeding stage of the batch fermentation of the above-mentioned recombinant strain BL21 (BAD) / pTAHL1 0 / pAR3-GR0-Km . When the cell density is 18g dry weight cells per liter, it is induced with "L-arabinose per liter". On the other hand, to reduce the fermentation cost, plant extracts rich in L-arabinose such as soybean extract are also used as inducers. In addition, according to the fermentation curve in Figure 2, the appropriate induction time is selected, such as 10 hours or 16 hours after the section feeding. The result is that the induction condition is 10 hours or 6 hours after the section feeding, and the estimated L-arabinose is used as the induction saturation. Induced by the amount of 0.10.2% soybean extract, the cell density of fermentation culture can reach about 35g dry weight cells per liter, and the enzyme volume activity reaches 2.92 U / mL. The total recombinant protein produced by the fermentation has a total of 8 760 U This yield is 100% of the protein quality obtained in the shake flask method. In addition, the stability of the plastids contained in the tested strains after the end of fermentation has also reached 100%. These results show that the strains developed by the present invention have High stability and scale-up production of a large number of recombinant proteins, which is extremely industrially practical. Efficacy of the invention According to the present invention, the T7 table is controlled by means of L-arabinose induction. The control method of the system requires only a trace amount of L-arabinose or the use of inexpensive plant extracts such as soybean extract to achieve the effect of inducing the production of a large amount of recombinant protein, which is particularly economical. In addition, in order to effectively utilize the present invention, The strains reach the goal of industrial mass production of recombinant protein 26 1230734. The present invention develops a high-cell-density fermentation strategy and successfully mass-produces recombinant proteins on a fermentation scale, the yield of which exceeds 1,000-fold flask-scale production.

27 1230734 【圖式簡單說明】 本發明進一步的較佳特徵,係位於申請專利範圍的獨立 項以及其後的實施例說明中,其係參考以下附圖: 圖一(a)為顯示本發明實施例之曲線圖,係說明不同濃度 的左旋阿拉伯糖誘導菌種所產生的蛋白質量。 圖一(b)為顯示本發明實施例之蛋白質電泳分析圖。 圖二為顯示本發明實施例之曲線圖,係說明饋料批次發 酵的進料階段以區段式進料法(長條狀區域)進行重組 菌種 BL21(BAD)/pTAHL10/pAR3-GR〇-Km 的高細胞密 度發酵。 表一為不同營養基質對於重組蛋白質生產的效應。 表二為質體在重組菌種BL21(BAD)和BL21(DE3)中之穩 定性。 【主要元件符號說明】27 1230734 [Brief description of the drawings] Further preferred features of the present invention are independent items in the scope of the patent application and the subsequent description of the embodiments, which refer to the following drawings: Figure 1 (a) shows the implementation of the present invention The graphs of the examples illustrate the quality of protein produced by L-arabinose-inducing bacteria at different concentrations. FIG. 1 (b) is a diagram showing a protein electrophoresis analysis example according to the present invention. FIG. 2 is a graph showing an example of the present invention, illustrating the feeding stage of the feed batch fermentation using the segmented feeding method (long strip-shaped area) for the recombinant strain BL21 (BAD) / pTAHL10 / pAR3-GR 〇-Km high cell density fermentation. Table 1 shows the effects of different nutritional matrices on recombinant protein production. Table 2 shows the stability of plastids in recombinant strains BL21 (BAD) and BL21 (DE3). [Description of main component symbols]

28 1230734 表一 營養基質 酵素比活性(U/mg乾重細胞) 誘導 非誘導 LB 0.202 0.004 LB+葡萄糖 0.033 0.003 S-M9+甘油 0.191 0.002 S-M9+葡萄糖 0.021 0.001 註解:表中所列的碳源濃度均為0.4%。 1230734 表二 細胞世代 BL2KBAD) BL2KDE3) LB S-M9 LB S-M9 10 100% 100% 100% 100% 30 100% 100% 70% 84% 50 100% 100% 50% 68% 100 96% 100% 20% 35% 註解·· S-M9營養基包含0.4%葡萄糖。28 1230734 Table 1. Specific activity of nutrient matrix enzymes (U / mg dry weight cells) Induced non-induced LB 0.202 0.004 LB + glucose 0.033 0.003 S-M9 + glycerol 0.191 0.002 S-M9 + glucose 0.021 0.001 Note: The carbon source concentrations listed in the table are all 0.4%. 1230734 Table 2 cell generation BL2KBAD) BL2KDE3) LB S-M9 LB S-M9 10 100% 100% 100% 100% 30 100% 100% 70% 84% 50 100% 100% 50% 68% 100 96% 100% 20 % 35% Notes · S-M9 contains 0.4% glucose.

Claims (1)

1230734 該重組蛋白質。 4.:申:範㈣1項所述之控制方法,其中在發酵階 ^ θ供的發酵液中含有葡萄糖為碳源,係以穩定該 貝體。 5. ^申=範圍第2項所述之控制方法,其中在進料階 提1、的進料液中含有甘油和葡萄糖為碳源,以利 ^走阿拉伯㈣導生產該選殖基因的產物和穩定該 質體。 6. 如申請範圍第2或5項所述之控制方法,其 基因的產物即為該重組蛋白質。. ^、殖 •如申^㈣第1項所述之控制方法,其中該細胞所達 到的高密度係每升18 g乾重細胞。 8·如申請範圍第1項所述之控制方法,其中在進料階段 所使用的進料方式,係包含區段式進料法。 9·如申請範圍第1項所述之控制方法,進一步包含一種 檢測方法,該檢測方法係以小規模提高該重組菌種數 量,加入左旋阿拉伯糖誘導產生一異源蛋白質 30 1230734 (heterologous protein) 〇 10.如申請範圍第9項所述之控制方法,其中該異源蛋白 質易形成内涵體(inclusion body)和具有潛在毒性, 用於檢測該T7表達系統的可行性。1230734 The recombinant protein. 4 .: Shen: The control method described in item 1 of Fan, wherein the fermentation broth supplied in the fermentation stage ^ θ contains glucose as a carbon source to stabilize the shell. 5. The control method described in item 2 of the scope, wherein the feed liquid of the feed stage 1 contains glycerol and glucose as carbon sources, so as to facilitate the production of the product of the selected gene by the Arabidopsis And stabilize the plastid. 6. According to the control method described in item 2 or 5 of the application scope, the product of the gene is the recombinant protein. ^, Colonization • The control method according to item 1 of Shen ^ ㈣, wherein the high density reached by the cells is 18 g dry weight cells per liter. 8. The control method according to item 1 of the application scope, wherein the feeding method used in the feeding stage includes a section feeding method. 9. The control method according to item 1 of the scope of application, further comprising a detection method, which increases the number of the recombinant strains on a small scale, and adds L-arabinose to induce the production of a heterologous protein 30 1230734 (heterologous protein) 〇10. The control method according to item 9 of the application scope, wherein the heterologous protein easily forms an inclusion body and has potential toxicity for detecting the feasibility of the T7 expression system. 3131
TW91113315A 2002-06-18 2002-06-18 Control of the T7 expression system by L-arabinose TWI230734B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW91113315A TWI230734B (en) 2002-06-18 2002-06-18 Control of the T7 expression system by L-arabinose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW91113315A TWI230734B (en) 2002-06-18 2002-06-18 Control of the T7 expression system by L-arabinose

Publications (1)

Publication Number Publication Date
TWI230734B true TWI230734B (en) 2005-04-11

Family

ID=36086236

Family Applications (1)

Application Number Title Priority Date Filing Date
TW91113315A TWI230734B (en) 2002-06-18 2002-06-18 Control of the T7 expression system by L-arabinose

Country Status (1)

Country Link
TW (1) TWI230734B (en)

Similar Documents

Publication Publication Date Title
JP5486029B2 (en) Increased lysine production by gene amplification
JP2021500914A5 (en)
CN113564190B (en) High-yield riboflavin escherichia coli engineering strain and construction method thereof
CN110373370B (en) Catalytic system coupled with ATP regeneration system and application of catalytic system in glutathione production process
CN110885803A (en) Recombinant glufosinate-ammonium dehydrogenase, genetically engineered bacterium and application of recombinant glufosinate-ammonium dehydrogenase in preparation of L-glufosinate-ammonium
CN106148296A (en) Production method of recombinant glutamine transaminase
JP2010515468A (en) L-arginine producing Corynebacterium glutamicum mutant and method for producing the same
CN118086167A (en) Genetically engineered bacterium for producing L-tryptophan and construction method and application thereof
CN111004761A (en) L-tyrosine gene engineering bacterium, method for producing L-tyrosine by using same and application thereof
CN106635945B (en) Recombinant strain, preparation method thereof and method for producing L-threonine
CN101065477A (en) Process for producing substances
CN115948402A (en) Recombinant Shewanella capable of producing 5-aminolevulinic acid and application thereof
CN114107159B (en) High-yield beta-alanine producing strain, construction method and application
TWI230734B (en) Control of the T7 expression system by L-arabinose
JP6991897B2 (en) Nucleic acids and vectors for controlling gene expression in non-phototrophic C1 metabolizing microorganisms, and transformants thereof
CN113943690B (en) Citrobacter welchii tpiA gene knockout mutant strain and application thereof
CN116121160A (en) Genetically engineered bacterium for over-expressing pyrB gene and method for producing L-arginine by using genetically engineered bacterium
CN110218691A (en) One plant of genetic engineering bacterium for synthesizing altheine and its construction method and application
CN108611357A (en) A kind of recombinant expression plasmid, transformant and its application
CN114317582A (en) Method for improving stability of arginine producing capacity of strain
TWI230735B (en) Control of the T7 expression system by heat
CN111378678B (en) Plasmid for strengthening hydroxyproline synthesis and construction and application thereof
CN113930379B (en) Beta-alanine producing strain, construction method and application
CN115124605B (en) High temperature resistant element mutant and application thereof in amino acid production
CN113249281B (en) Recombinant bacterium for producing phloroglucinol by using ethanol and construction method and application thereof

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees